AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (16.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Broad-spectrum anticoronaviral activity of the traditional herbal medicine Mahuangtang by targeting the multistep viral infection process: virus entry, Mpro, PLpro, RdRp and IFN induction

Jiwon Yoona,Δ, Young-Hee Jinb,Δ, Yeonhwa Kimc, Eun Young Ohc, Sohyun Parkc, Jung Sun Mind, In Jin Hae, Sanghyun Kimf, Hakjin Kimg, Sang-Myeong Leec( ), Sunoh Kwond( )
Korean Medicine Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea
Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea
Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea
Korean Medicine Clinical Trial Center (K-CTC), Kyung Hee University Korean Medicine Hospital, Seoul 02454, Republic of Korea
Department of Medical Classics, College of Korean Medicine, Daejeon University, Daejeon 34520, Republic of Korea
In Quantio, Gene On Biotech, Daejeon 35229, Republic of Korea

∆ These authors contributed equally to this work.

Show Author Information

Abstract

Ephedra decoction, Mahuangtang (MHT), is a traditional herbal formula comprising Ephedrae sinica (ES), Prunus armeniaca (PA), Cinnamomum cassia(CC), and Glycyrrhiza uralensis (GU). MHT is used to treat colds, influenza, and other respiratory conditions. This study investigates the anticoronaviral effect of MHT and elucidates its mode of action and the active antiviral components of MHT. UHPLC-MS/MS analysis showed the holistic quality and equivalency between MHT and a mixture of four herbal components and identified nine representative compounds in MHT. The inhibitory activity of MHT and its components was examined with HCoV-OC43, SARS-CoV-2, its omicron variants, and pseudotyped lentiviruses. Time-of-addition assay, viral attachment assay, viral penetration assay, virucidal assay, and SARS-CoV-2 Mpro, PLpro, and RdRp activity assay were performed. MHT and its components, ES, CC, and GU, except PA, inhibited coronavirus infection. While MHT, and its components ES, and CC exhibited the suppression of virus entry with a virucidal activity, GU demonstrated inhibition of viral infection in the late stage. PA and its compound, amygdalin, did not inhibit coronavirus infection. Furthermore, Cinnamic aldehyde in CC and liquiritin, liquiritigenin, glycyrrhizin, and glabridin in GU were the active compounds of MHT but not ephedrine alkaloids in ES. MHT and its components inhibited the activity of Mpro and PLpro proteases and RdRp. Molecular docking analysis showed the binding affinity between RdRp and glabridin and between RBD-ACE2 and cinnamic aldehyde. Additionally, we showed that MHT induced the expression of IFN-related antiviral genes by activating the STAT1 pathway. MHT exhibited the potential to function as a multifaceted therapeutic candidate for treating broad-spectrum coronavirus infection by targeting multiple stages of viral infection.

References

【1】
【1】
 
 
Chinese Journal of Natural Medicines
Pages 1163-1175

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Yoon J, Jin Y-H, Kim Y, et al. Broad-spectrum anticoronaviral activity of the traditional herbal medicine Mahuangtang by targeting the multistep viral infection process: virus entry, Mpro, PLpro, RdRp and IFN induction. Chinese Journal of Natural Medicines, 2026, 24(10): 1163-1175. https://doi.org/10.1016/S1875-5364(26)61212-5

6

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 23 September 2025
Revised: 13 June 2026
Accepted: 15 June 2026
Published: 20 October 2026
© 2026, China Pharmaceutical University.

This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).